Status:
COMPLETED
EUS-Guided Pancreatic Injection of Cyst (EPIC) Trial
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Indiana University School of Medicine
Conditions:
Pancreatic Cystadenoma
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of the study is to learn about a new treatment for pancreatic cystic lesions. The injection of alcohol into cysts is a common way of treating cysts of the liver, kidney, and thyroid. We wo...
Detailed Description
Cystic lesions of the kidney, thyroid, and liver are commonly treated with ethanol injections into the cyst cavity. The contact with ethanol results in rapid elimination of epithelial cells lining cys...
Eligibility Criteria
Inclusion
- Patients with a pancreatic cyst (1-5cm in diameter)
- Capable of safely undergoing endoscopy with conscious sedation
Exclusion
- Coagulopathy (INR\>1.5, PTT\>100, platelets of\< 50k)
- Active infection of the cyst
- Unstable cardio-pulmonary disease (active angina, home O2, or pulmonary edema)
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00233038
Start Date
January 1 2005
End Date
March 1 2008
Last Update
October 29 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University Medical Center
Indianapolis, Indiana, United States, 46202-5114